Latest CellaVision News & Updates

See the latest news and media coverage for CellaVision. We track all announcements, press releases, and industry mentions in real time, all in one place.

CellaVision

Digital hematology microscopy solutions provider

cellavision.com

Headquarters: Lund, Sweden
Founded year: 1994
Company type: Public company
Number of employees: 280–500
Industry: Advanced Medical Equipment & Technology

Last updated October 29

Latest news about CellaVision

In short: CellaVision reported Q3 2026 sales of SEK 200 million and a 32% EBITDA margin.

Company announcements

October 29 CellaVision

CellaVision reports Q3 2026 net sales of 200 MSEK

EBITDA reached 64 MSEK with a 32% margin, driven by strong US demand and reagent growth in Japan.

July 17 CellaVision

CellaVision reports all-time high Q2 sales in Americas

The report also notes positive customer interest from the new CE-marked Bone Marrow Aspirate Application launch in EMEA.

July 17 CellaVision

CellaVision reports Q2 2026 interim results

Net sales reached SEK 200 million with an all-time high in the Americas. New CEO Steve Ferguson takes office, and the BMA application launches.

April 24 CellaVision

CellaVision releases Q1 2026 interim report

Report shows softer quarter from lower EMEA sales. They launched CE-marked Bone Marrow Aspirate Application and software upgrade.

Media coverage

October 29 Investing.com

Earnings Report CellaVision: Q3 2026 sales +13.6%, stock +4%

CellaVision reported that third-quarter sales increased by 13.6% compared to the previous year, driven by stronger demand in the Americas and...

October 28 Marketscreener

CellaVision AB (publ) reports results for the third quarter and the nine months ended September 30, 2026

CellaVision AB has announced the results for the third quarter and the nine months ended September 30, 2026. In the third quarter, it reported...

October 26 Dagens industri

Cellavision reports higher results than expected

Medical technology company Cellavision exceeded expectations with a stronger quarterly result during the third quarter of 2026.

July 17 Finanznachrichten

CellaVision: Sales recovery with all-time high in Americas

Q2, 2026: 27% (31)April 1 - June 30, 2026Net sales increased by 4.5% (1.9) to SEK 200 m (191).Sales increased organically by 5.6% (7.6), currency...

Never miss news about CellaVision

Track CellaVision and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

CellaVision competitors & trending companies

Browse news for competitors to CellaVision and other trending companies.